InsidersTradesSigma
Track the 리브스메드 stock price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on the KR market, under the supervision of DART (FSS). Operating in the Health Care sector, 리브스메드 has recorded 21 reports. Market capitalisation: €1,009.5bn. The latest transaction was disclosed on 22 April 2026 (Purchase). Among the most active insiders: 스톤브릿지벤처스. Every trade is openly available.
21
Insider Decl.
n/a
Thresholds
n/a
14 ops.
Buy Volume
n/a
6 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 April 2026
Declarations21 total
1,465,662 sharesKRXDART:20260407003261
21 of 21 declarations
Acerca de 리브스메드
리브스메드 opera en el sector de la salud y farmacéutico, cotizando en el mercado XKRX. La empresa se enfoca en el desarrollo de soluciones innovadoras para la atención médica.